Giranda V L
Sterling Winthrop Pharmaceuticals Research Division, Collegeville, PA 19426-0900.
Structure. 1994 Aug 15;2(8):695-8. doi: 10.1016/s0969-2126(00)00069-1.
Improved knowledge of rhinovirus structures makes it possible to identify three promising targets for broad-spectrum antirhinoviral drugs.